Literature DB >> 16503341

The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.

Angela J Fagerness1, Maureen T Flaherty, Stephanie T Perry, Bin Jia, Susan L Payne, Frederick J Fuller.   

Abstract

Equine infectious anemia virus (EIAV) is a macrophage-tropic lentivirus that persistently infects horses and causes a disease that is characterized by periodic episodes of fever, thrombocytopenia, and viremia. EIAV encodes only four regulatory/accessory genes, (tat, rev, ttm, and S2) and is the least genetically complex of all known lentiviruses. We sought to determine the role of the EIAV S2 accessory gene of EIAV by introducing mutations that would prevent S2 expression on the p19/wenv17 infectious molecular clone. Virus derived from the p19/wenv17 molecular clone is highly virulent and routinely fatal when given in high doses (J. Virol. 72 (1998) 483). In contrast, an S2 deletion mutant on the p19/wenv17 background is unable to induce acute disease and plasma virus loads were reduced by 2.5 to 4.0 logs at 15 days post-infection. The S2 deleted virus failed to produce any detectable clinical signs during a 5-month observation period. These results demonstrate that S2 gene expression is essential for disease expression of EIAV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503341     DOI: 10.1016/j.virol.2005.12.041

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3.

Authors:  Ajit Chande; Emilia Cristiana Cuccurullo; Annachiara Rosa; Serena Ziglio; Susan Carpenter; Massimo Pizzato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

2.  The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.

Authors:  Iqbal Ahmad; Sunan Li; Rongrong Li; Qingqing Chai; Lixin Zhang; Bin Wang; Changqing Yu; Yong-Hui Zheng
Journal:  J Biol Chem       Date:  2019-03-12       Impact factor: 5.157

3.  Identification of cellular proteins interacting with equine infectious anemia virus S2 protein.

Authors:  Lina Covaleda; Bich-Ty Gno; Fredrick J Fuller; Susan L Payne
Journal:  Virus Res       Date:  2010-04-24       Impact factor: 3.303

4.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

5.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

6.  Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.

Authors:  Xin Yin; Zhe Hu; Qinyong Gu; Xingliang Wu; Yong-Hui Zheng; Ping Wei; Xiaojun Wang
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

7.  SAMHD1 specifically restricts retroviruses through its RNase activity.

Authors:  Jongsu Choi; Jeongmin Ryoo; Changhoon Oh; Sungyeon Hwang; Kwangseog Ahn
Journal:  Retrovirology       Date:  2015-06-02       Impact factor: 4.602

8.  A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses.

Authors:  Xue-Feng Wang; Shuai Wang; Qiang Liu; Yue-Zhi Lin; Cheng Du; Yan-Dong Tang; Lei Na; Xiaojun Wang; Jian-Hua Zhou
Journal:  Viruses       Date:  2014-11-10       Impact factor: 5.048

9.  Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.

Authors:  Yadvinder S Ahi; Shu Zhang; Yashna Thappeta; Audrey Denman; Amin Feizpour; Suryaram Gummuluru; Bjoern Reinhard; Delphine Muriaux; Matthew J Fivash; Alan Rein
Journal:  mBio       Date:  2016-11-22       Impact factor: 7.867

Review 10.  SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV.

Authors:  Gracia Viviana Gonzalez-Enriquez; Martha Escoto-Delgadillo; Eduardo Vazquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  J Immunol Res       Date:  2017-11-22       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.